Bruker Corp (FRA:BKD)
€ 60.84 -3.22 (-5.03%) Market Cap: 8.80 Bil Enterprise Value: 9.83 Bil PE Ratio: 23.84 PB Ratio: 6.73 GF Score: 95/100

Bruker Corp at Cowen Health Care Conference Transcript

Mar 12, 2019 / 02:40PM GMT
Release Date Price: €34.02 (+2.66%)
Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

All right, good morning. I'm Doug Schenkel, one of the healthcare analysts here at Cowen. Welcome to our presentation and fireside chat with Bruker. Up here at the front of the room with us, we have Gerald Herman, who is Bruker's Chief Financial Officer; and Miroslava Minkova, who heads Bruker's Investor Relations team.

Just to give you a roadmap for the next half hour, Gerald's going to run through some prepared remarks for probably the next 10, 15 minutes.

We'll then transition into our traditional fireside chat format, with the time remaining. We'll probably focus primarily on Bruker's Project Accelerate initiatives, margin expansion opportunities and capital deployment plans. Whatever we don't get to here, we can continue discussing in the breakout next door.

So with that, Gerald, thanks for being here and let me turn it over to you.

Gerald N. Herman
Bruker Corporation - CFO, VP & Corporate Controller

Thanks, very much, Doug.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot